Adhesion of diarrheagenic escherichia coli and inhibition by glycocompounds engaged in the mucosal innate immunity

Biology

Volumn 2, Issue 2, 2013, Pages 810-831

  Pereira, Alex L ^a   Giugliano, Loreny G ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Diarrheagenic Escherichia coli; Human milk; Inhibition; Lactoferrin; Secretory component

Indexed keywords

EID: 84901378531     PISSN: None     EISSN: 20797737     Source Type: Journal    
DOI: 10.3390/biology2020810     Document Type: Review

References (108)

1. Kaper, J.B.; Nataro, J.P.; Mobley, H.L. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2004, 2, 123-140.
2. Sekirov, I.; Russell, S.L.; Antunes, L.C.; Finlay, B.B. Gut microbiota in health and disease. Physiol. Rev. 2010, 90, 859-904.
3. Fanaro, S.; Chierici, R.; Guerrini, P.; Vigi, V. Intestinal microflora in early infancy: Composition and development. Acta Paediatr. Suppl. 2003, 91, 48-55.
4. Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T.; et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59-65.
5. Nataro, J.P.; Kaper, J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 1998, 11, 142-201.
6. Orskov, F. On the occurrence of E. coli belonging to O-group 26 in cases of infantile diarrhoea and white scours. Acta Pathol. Microbiol. Scand. 1951, 29, 373-378.
7. Ewing, W.H.; Tanner, K.E.; Tatum, H.W. A new serotype of Escherichia coli associated with infantile diarrhea. Public Health Rep. 1955, 70, 107-114.
8. Evans, D.G.; Silver, R.P.; Evans, D.J., Jr.; Chase, D.G.; Gorbach, S.L. Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect. Immun. 1975, 12, 656-667.
9. Evans, D.G.; Evans, D.J., Jr. New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Esherichia coli of serogroups O6 and O8. Infect. Immun. 1978, 21, 638-647.
10. Scaletsky, I.C.; Silva, M.L.; Trabulsi, L.R. Distinctive patterns of adherence of enteropathogenic Esherichia coli to HeLa cells. Infect. Immun. 1984, 45, 534-536.
11. Nataro, J.P.; Scaletsky, I.C.; Kaper, J.B.; Levine, M.M.; Trabulsi, L.R. Plasmid-mediated factors conferring diffuse and localized adherence of enteropathogenic Esherichia coli. Infect. Immun. 1985, 48, 378-383.
12. Giron, J.A.; Ho, A.S.; Schoolnik, G.K. An inducible bundle-forming pilus of enteropathogenic Esherichia coli. Science 1991, 254, 710-713.
13. Giron, J.A.; Ho, A.S.; Schoolnik, G.K. Characterization of fimbriae produced by enteropathogenic Esherichia coli. J. Bacteriol. 1993, 175, 7391-7403.
14. Nataro, J.P.; Deng, Y.; Maneval, D.R.; German, A.L.; Martin, W.C.; Levine, M.M. Aggregative adherence fimbriae I of enteroaggregative Esherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect. Immun. 1992, 60, 2297-2304.
15. Bilge, S.S.; Clausen, C.R.; Lau, W.; Moseley, S.L. Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Esherichia coli to HEp-2 cells. J. Bacteriol. 1989, 171, 4281-4289.
16. Knutton, S.; McConnell, M.M.; Rowe, B.; McNeish, A.S. Adhesion and ultrastructural properties of human enterotoxigenic Esherichia coli producing colonization factor antigens III and IV. Infect. Immun. 1989, 57, 3364-3371.
17. Fitzhenry, R.J.; Pickard, D.J.; Hartland, E.L.; Reece, S.; Dougan, G.; Phillips, A.D.; Frankel, G. Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Esherichia coli O157:H7. Gut 2002, 50, 180-185.
18. Phillips, A.D.; Frankel, G. Intimin-mediated tissue specificity in enteropathogenic Esherichia coli interaction with human intestinal organ cultures. J. Infect. Dis. 2000, 181, 1496-1500.
19. Frankel, G.; Lider, O.; Hershkoviz, R.; Mould, A.P.; Kachalsky, S.G.; Candy, D.C.; Cahalon, L.; Humphries, M.J.; Dougan, G. The cell-binding domain of intimin from enteropathogenic Esherichia coli binds to beta1 integrins. J. Biol. Chem. 1996, 271, 20359-20364.
20. Farfan, M.J.; Cantero, L.; Vidal, R.; Botkin, D.J.; Torres, A.G. Long polar fimbriae of enterohemorrhagic Esherichia coli O157:H7 bind to extracellular matrix proteins. Infect. Immun. 2011, 79, 3744-3750.
21. Hicks, S.; Candy, D.C.; Phillips, A.D. Adhesion of enteroaggregative Esherichia coli to pediatric intestinal mucosa in vitro. Infect. Immun. 1996, 64, 4751-4760.
22. Knutton, S.; Shaw, R.K.; Bhan, M.K.; Smith, H.R.; McConnell, M.M.; Cheasty, T.; Williams, P.H.; Baldwin, T.J. Ability of enteroaggregative Esherichia coli strains to adhere in vitro to human intestinal mucosa. Infect. Immun. 1992, 60, 2083-2091.
23. Le, B.C.; Servin, A.L. Diffusely adherent Esherichia coli strains expressing Afa/Dr adhesins (Afa/Dr DAEC): hitherto unrecognized pathogens. FEMS Microbiol. Lett. 2006, 256, 185-194.
24. Peiffer, I.; Servin, A.L.; Bernet-Camard, M.F. Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Esherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells. Infect. Immun. 1998, 66, 4036-4042.
25. Bernet-Camard, M.F.; Coconnier, M.H.; Hudault, S.; Servin, A.L. Pathogenicity of the diffusely adhering strain Esherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells. Infect. Immun. 1996, 64, 1918-1928.
26. Lan, R.; Alles, M.C.; Donohoe, K.; Martinez, M.B.; Reeves, P.R. Molecular evolutionary relationships of enteroinvasive Esherichia coli and Shigella spp. Infect. Immun. 2004, 72, 5080-5088.
27. Parsot, C. Shigella spp. and enteroinvasive Esherichia coli pathogenicity factors. FEMS Microbiol. Lett. 2005, 252, 11-18.
28. Sansonetti, P. Host-pathogen interactions: The seduction of molecular cross talk. Gut 2002, 50, III2-III8.
29. Sansonetti, P.J. Rupture, invasion and inflammatory destruction of the intestinal barrier by Shigella, making sense of prokaryote-eukaryote cross-talks. FEMS Microbiol. Rev. 2001, 25, 3-14.
30. Sansonetti, P.J.; D'Hauteville, H.; Ecobichon, C.; Pourcel, C. Molecular comparison of virulence plasmids in Shigella and enteroinvasive Esherichia coli. Ann. Microbiol. (Paris) 1983, 134A, 295-318.
31. Honda, T.; Cakir, N.; Arita, M.; Miwatani, T. Purification and characterization of the CS2 pili of colonization factor antigen II produced by human enterotoxigenic Esherichia coli. Microbiol. Immunol. 1989, 33, 265-275.
32. Isidean, S.D.; Riddle, M.S.; Savarino, S.J.; Porter, C.K. A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. Vaccine 2011, 29, 6167-6178.
33. Wolf, M.K. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Esherichia coli. Clin. Microbiol. Rev. 1997, 10, 569-584.
34. Mu, X.Q.; Savarino, S.J.; Bullitt, E. The three-dimensional structure of CFA/I adhesion pili: Traveler's diarrhea bacteria hang on by a spring. J. Mol. Biol. 2008, 376, 614-620.
35. Pieroni, P.; Worobec, E.A.; Paranchych, W.; Armstrong, G.D. Identification of a human erythrocyte receptor for colonization factor antigen I pili expressed by H10407 enterotoxigenic Esherichia coli. Infect. Immun. 1988, 56, 1334-1340.
36. Jansson, L.; Tobias, J.; Lebens, M.; Svennerholm, A.M.; Teneberg, S. The major subunit, CfaB, of colonization factor antigen i from enterotoxigenic Esherichia coli is a glycosphingolipid binding protein. Infect. Immun. 2006, 74, 3488-3497.
37. Levine, M.M.; Ristaino, P.; Sack, R.B.; Kaper, J.B.; Orskov, F.; Orskov, I. Colonization factor antigens I and II and type 1 somatic pili in enterotoxigenic Esherichia coli: Relation to enterotoxin type. Infect. Immun. 1983, 39, 889-897.
38. Oro, H.S.; Kolsto, A.B.; Wenneras, C.; Svennerholm, A.M. Identification of asialo GM1 as a binding structure for Esherichia coli colonization factor antigens. FEMS Microbiol. Lett. 1990, 60, 289-292.
39. Roy, S.P.; Rahman, M.M.; Yu, X.D.; Tuittila, M.; Knight, S.D.; Zavialov, A.V. Crystal structure of enterotoxigenic Esherichia coli colonization factor CS6 reveals a novel type of functional assembly. Mol. Microbiol. 2012, 86, 1100-1115.
40. Jansson, L.; Tobias, J.; Jarefjall, C.; Lebens, M.; Svennerholm, A.M.; Teneberg, S. Sulfatide recognition by colonization factor antigen CS6 from enterotoxigenic Esherichia coli. PLoS One 2009, 4, e4487.
41. Li, Y.F.; Poole, S.; Nishio, K.; Jang, K.; Rasulova, F.; McVeigh, A.; Savarino, S.J.; Xia, D.; Bullitt, E. Structure of CFA/I fimbriae from enterotoxigenic Esherichia coli. Proc. Natl. Acad. Sci. USA 2009, 106, 10793-10798.
42. Thomas, L.V.; McConnell, M.M.; Rowe, B.; Field, A.M. The possession of three novel coli surface antigens by enterotoxigenic Esherichia coli strains positive for the putative colonization factor PCF8775. J. Gen. Microbiol. 1985, 131, 2319-2326.
43. Wolf, M.K.; de Haan, L.A.; Cassels, F.J.; Willshaw, G.A.; Warren, R.; Boedeker, E.C.; Gaastra, W. The CS6 colonization factor of human enterotoxigenic Esherichia coli contains two heterologous major subunits. FEMS Microbiol. Lett. 1997, 148, 35-42.
44. Ghosal, A.; Bhowmick, R.; Banerjee, R.; Ganguly, S.; Yamasaki, S.; Ramamurthy, T.; Hamabata, T.; Chatterjee, N.S. Characterization and studies of the cellular interaction of native colonization factor CS6 purified from a clinical isolate of enterotoxigenic Esherichia coli. Infect. Immun. 2009, 77, 2125-2135.
45. Tobias, J.; Lebens, M.; Kallgard, S.; Nicklasson, M.; Svennerholm, A.M. Role of different genes in the CS6 operon for surface expression of Enterotoxigenic Esherichia coli colonization factor CS6. Vaccine 2008, 26, 5373-5380.
46. Tobe, T.; Sasakawa, C. Role of bundle-forming pilus of enteropathogenic Esherichia coli in host cell adherence and in microcolony development. Cell Microbiol. 2001, 3, 579-585.
47. Tobe, T.; Sasakawa, C. Species-specific cell adhesion of enteropathogenic Esherichia coli is mediated by type IV bundle-forming pili. Cell Microbiol. 2002, 4, 29-42.
48. Cleary, J.; Lai, L.C.; Shaw, R.K.; Straatman-Iwanowska, A.; Donnenberg, M.S.; Frankel, G.; Knutton, S. Enteropathogenic Esherichia coli (EPEC) adhesion to intestinal epithelial cells: Role of bundle-forming pili (BFP), EspA filaments and intimin. Microbiology 2004, 150, 527-538.
49. Bieber, D.; Ramer, S.W.; Wu, C.Y.; Murray, W.J.; Tobe, T.; Fernandez, R.; Schoolnik, G.K. Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Esherichia coli. Science 1998, 280, 2114-2118.
50. Oswald, E.; Schmidt, H.; Morabito, S.; Karch, H.; Marches, O.; Caprioli, A. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Esherichia coli: Characterization of a new intimin variant. Infect. Immun. 2000, 68, 64-71.
51. Kelly, G.; Prasannan, S.; Daniell, S.; Fleming, K.; Frankel, G.; Dougan, G.; Connerton, I.; Matthews, S. Structure of the cell-adhesion fragment of intimin from enteropathogenic Esherichia coli. Nat. Struct. Biol. 1999, 6, 313-318.
52. Frankel, G.; Candy, D.C.; Fabiani, E.; du-Bobie, J.; Gil, S.; Novakova, M.; Phillips, A.D.; Dougan, G. Molecular characterization of a carboxy-terminal eukaryotic-cell-binding domain of intimin from enteropathogenic Esherichia coli. Infect. Immun. 1995, 63, 4323-4328.
53. Muza-Moons, M.M.; Koutsouris, A.; Hecht, G. Disruption of cell polarity by enteropathogenic Esherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences. Infect. Immun. 2003, 71, 7069-7078.
54. Torres, A.G.; Giron, J.A.; Perna, N.T.; Burland, V.; Blattner, F.R.; velino-Flores, F.; Kaper, J.B. Identification and characterization of lpfABCC'DE, a fimbrial operon of enterohemorrhagic Esherichia coli O157:H7. Infect. Immun. 2002, 70, 5416-5427.
55. Torres, A.G.; Kanack, K.J.; Tutt, C.B.; Popov, V.; Kaper, J.B. Characterization of the second long polar (LP) fimbriae of Esherichia coli O157:H7 and distribution of LP fimbriae in other pathogenic E. coli strains. FEMS Microbiol. Lett. 2004, 238, 333-344.
56. Fitzhenry, R.; Dahan, S.; Torres, A.G.; Chong, Y.; Heuschkel, R.; Murch, S.H.; Thomson, M.; Kaper, J.B.; Frankel, G.; Phillips, A.D. Long polar fimbriae and tissue tropism in Esherichia coli O157:H7. Microb. Infect. 2006, 8, 1741-1749.
57. Jordan, D.M.; Cornick, N.; Torres, A.G.; an-Nystrom, E.A.; Kaper, J.B.; Moon, H.W. Long polar fimbriae contribute to colonization by Esherichia coli O157:H7 in vivo. Infect. Immun. 2004, 72, 6168-6171.
58. Czeczulin, J.R.; Balepur, S.; Hicks, S.; Phillips, A.; Hall, R.; Kothary, M.H.; Navarro-Garcia, F.; Nataro, J.P. Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Esherichia coli. Infect. Immun. 1997, 65, 4135-4145.
59. Bernier, C.; Gounon, P.; Le, B.C. Identification of an aggregative adhesion fimbria (AAF) type III-encoding operon in enteroaggregative Esherichia coli as a sensitive probe for detecting the AAF-encoding operon family. Infect. Immun. 2002, 70, 4302-4311.
60. Boisen, N.; Struve, C.; Scheutz, F.; Krogfelt, K.A.; Nataro, J.P. New adhesin of enteroaggregative Esherichia coli related to the Afa/Dr/AAF family. Infect. Immun. 2008, 76, 3281-3292.
61. Boll, E.J.; Struve, C.; Sander, A.; Demma, Z.; Nataro, J.P.; McCormick, B.A.; Krogfelt, K.A. The fimbriae of enteroaggregative Esherichia coli induce epithelial inflammation in vitro and in a human intestinal xenograft model. J. Infect. Dis. 2012, 206, 714-722.
62. Konar, M.; Sachin, O.; Priya, A.; Ghosh, S. Identification of key proteins of cultured human intestinal cells involved in interaction with enteroaggregative Esherichia coli. FEMS Immunol. Med. Microbiol. 2012, 66, 177-190.
63. Piva, I.C.; Pereira, A.L.; Ferraz, L.R.; Silva, R.S.; Vieira, A.C.; Blanco, J.E.; Blanco, M.; Blanco, J.; Giugliano, L.G. Virulence markers of enteroaggregative Esherichia coli isolated from children and adults with diarrhea in Brasilia, Brazil. J. Clin. Microbiol. 2003, 41, 1827-1832.
64. Pereira, A.L.; Ferraz, L.R.; Silva, R.S.; Giugliano, L.G. Enteroaggregative Esherichia coli virulence markers: Positive association with distinct clinical characteristics and segregation into 3 enteropathogenic E. coli serogroups. J. Infect. Dis. 2007, 195, 366-374.
65. Boisen, N.; Scheutz, F.; Rasko, D.A.; Redman, J.C.; Persson, S.; Simon, J.; Kotloff, K.L.; Levine, M.M.; Sow, S.; Tamboura, B.; et al. Genomic characterization of enteroaggregative Esherichia coli from children in Mali. J. Infect. Dis. 2012, 205, 431-444.
66. Monteiro-Neto, V.; Bando, S.Y.; Moreira-Filho, C.A.; Giron, J.A. Characterization of an outer membrane protein associated with haemagglutination and adhesive properties of enteroaggregative Esherichia coli O111:H12. Cell Microbiol. 2003, 5, 533-547.
67. Dudley, E.G.; Abe, C.; Ghigo, J.M.; Latour-Lambert, P.; Hormazabal, J.C.; Nataro, J.P. An IncI1 plasmid contributes to the adherence of the atypical enteroaggregative Esherichia coli strain C1096 to cultured cells and abiotic surfaces. Infect. Immun. 2006, 74, 2102-2114.
68. Pereira, A.L.; Silva, T.N.; Gomes, A.C.; Araujo, A.C.; Giugliano, L.G. Diarrhea-associated biofilm formed by enteroaggregative Esherichia coli and aggregative Citrobacter freundii: A consortium mediated by putative F pili. BMC Microbiol. 2010, 10, 57.
69. Tacket, C.O.; Moseley, S.L.; Kay, B.; Losonsky, G.; Levine, M.M. Challenge studies in volunteers using Esherichia coli strains with diffuse adherence to HEp-2 cells. J. Infect. Dis. 1990, 162, 550-552.
70. Mansan-Almeida, R.; Pereira, A.L.; Giugliano, L.G. Diffusely adherent Esherichia coli strains isolated from children and adults constitute two different populations. BMC Microbiol. 2013, 13, 22.
71. Arikawa, K.; Meraz, I.M.; Nishikawa, Y.; Ogasawara, J.; Hase, A. Interleukin-8 secretion by epithelial cells infected with diffusely adherent Esherichia coli possessing Afa adhesin-coding genes. Microbiol. Immunol. 2005, 49, 493-503.
72. Fujihara, S.; Arikawa, K.; Aota, T.; Tanaka, H.; Nakamura, H.; Wada, T.; Hase, A.; Nishikawa, Y. Prevalence and properties of diarrheagenic Esherichia coli among healthy individuals in Osaka City, Japan. Jpn. J. Infect. Dis. 2009, 62, 318-323.
73. Servin, A.L. Pathogenesis of Afa/Dr diffusely adhering Esherichia coli. Clin. Microbiol. Rev. 2005, 18, 264-292.
74. Baranov, V.; Hammarstrom, S. Carcinoembryonic antigen (CEA) and CEA-related cell adhesion molecule 1 (CEACAM1), apically expressed on human colonic M cells, are potential receptors for microbial adhesion. Histochem. Cell Biol. 2004, 121, 83-89.
75. Guignot, J.; Peiffer, I.; Bernet-Camard, M.F.; Lublin, D.M.; Carnoy, C.; Moseley, S.L.; Servin, A.L. Recruitment of CD55 and CD66e brush border-associated glycosylphosphatidylinositol-anchored proteins by members of the Afa/Dr diffusely adhering family of Esherichia coli that infect the human polarized intestinal Caco-2/TC7 cells. Infect. Immun. 2000, 68, 3554-3563.
76. O'Ryan, M.; Prado, V.; Pickering, L.K. A millennium update on pediatric diarrheal illness in the developing world. Semin. Pediatr. Infect. Dis. 2005, 16, 125-136.
77. Lamberti, L.M.; Fischer Walker, C.L.; Noiman, A.; Victora, C.; Black, R.E. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011, 11, S15.
78. Svennerholm, A.M.; Tobias, J. Vaccines against enterotoxigenic Esherichia coli. Exp. Rev. Vaccines. 2008, 7, 795-804.
79. Tobias, J.; Svennerholm, A.M. Strategies to overexpress enterotoxigenic Esherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates. Appl. Microbiol. Biotechnol. 2012, 93, 2291-2300.
80. Work Group on Breastfeeding. Breastfeeding and the use of human milk-American Academy of Pediatrics. Pediatrics 1997, 100, 1035-1039.
81. Gartner, L.M.; Morton, J.; Lawrence, R.A.; Naylor, A.J.; O'Hare, D.; Schanler, R.J.; Eidelman, A.I. Breastfeeding and the use of human milk. Pediatrics 2005, 115, 496-506.
82. Giugliano, L.G.; Ribeiro, S.T.; Vainstein, M.H.; Ulhoa, C.J. Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Esherichia coli. J. Med. Microbiol. 1995, 42, 3-9.
83. Morrow, A.L.; Ruiz-Palacios, G.M.; Jiang, X.; Newburg, D.S. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J. Nutr. 2005, 135, 1304-1307.
84. Coppa, G.V.; Zampini, L.; Galeazzi, T.; Facinelli, B.; Ferrante, L.; Capretti, R.; Orazio, G. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Esherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr. Res. 2006, 59, 377-382.
85. Oliveira, I.R.; de Araujo, A.N.; Bao, S.N.; Giugliano, L.G. Binding of lactoferrin and free secretory component to enterotoxigenic Esherichia coli. FEMS Microbiol. Lett. 2001, 203, 29-33.
86. De Araujo, A.N.; Giugliano, L.G. Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Esherichia coli to HeLa cells. BMC Microbiol. 2001, 1, 25.
87. Ochoa, T.J.; Noguera-Obenza, M.; Ebel, F.; Guzman, C.A.; Gomez, H.F.; Cleary, T.G. Lactoferrin impairs type III secretory system function in enteropathogenic Esherichia coli. Infect. Immun. 2003, 71, 5149-5155.
88. Martin-Sosa, S.; Martin, M.J.; Hueso, P. The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Esherichia coli human strains. J. Nutr. 2002, 132, 3067-3072.
89. Nascimento de, A.A.; Giugliano, L.G. Human milk fractions inhibit the adherence of diffusely adherent Esherichia coli (DAEC) and enteroaggregative E. coli (EAEC) to HeLa cells. FEMS Microbiol. Lett. 2000, 184, 91-94.
90. Kawasaki, Y.; Tazume, S.; Shimizu, K.; Matsuzawa, H.; Dosako, S.; Isoda, H.; Tsukiji, M.; Fujimura, R.; Muranaka, Y.; Isihida, H. Inhibitory effects of bovine lactoferrin on the adherence of enterotoxigenic Esherichia coli to host cells. Biosci. Biotechnol. Biochem. 2000, 64, 348-354.
91. Flores-Villasenor, H.; Canizalez-Roman, A.; de la, G.M.; Nazmi, K.; Bolscher, J.G.; Leon-Sicairos, N. Lactoferrin and lactoferrin chimera inhibit damage caused by enteropathogenic Esherichia coli in HEp-2 cells. Biochimie 2012, 94, 1935-1942.
92. Flores-Villasenor, H.; Canizalez-Roman, A.; Velazquez-Roman, J.; Nazmi, K.; Bolscher, J.G.; Leon-Sicairos, N. Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Esherichia coli O157:H7 infection. Biochem. Cell Biol. 2012, 90, 405-411.
93. Ochoa, T.J.; Brown, E.L.; Guion, C.E.; Chen, J.Z.; McMahon, R.J.; Cleary, T.G. Effect of lactoferrin on enteroaggregative E. coli (EAEC). Biochem. Cell Biol. 2006, 84, 369-376.
94. Perrier, C.; Sprenger, N.; Corthesy, B. Glycans on secretory component participate in innate protection against mucosal pathogens. J. Biol. Chem. 2006, 281, 14280-14287.
95. Gonzalez-Chavez, S.A.; Arevalo-Gallegos, S.; Rascon-Cruz, Q. Lactoferrin: Structure, function and applications. Int. J. Antimicrob. Agents 2009, 33, 301-308.
96. Vogel, H.J. Lactoferrin, a bird's eye view. Biochem. Cell Biol. 2012, 90, 233-244.
97. Steiner, T.S.; Lima, A.A.; Nataro, J.P.; Guerrant, R.L. Enteroaggregative Esherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J. Infect. Dis. 1998, 177, 88-96.
98. Greenberg, D.E.; Jiang, Z.D.; Steffen, R.; Verenker, M.P.; DuPont, H.L. Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Esherichia coli pathogenicity. J. Infect. Dis. 2002, 185, 944-949.
99. Snoeck, V.; Peters, I.R.; Cox, E. The IgA system: A comparison of structure and function in different species. Vet. Res. 2006, 37, 455-467.
100. Phalipon, A.; Corthesy, B. Novel functions of the polymeric Ig receptor: Well beyond transport of immunoglobulins. Trends Immunol. 2003, 24, 55-58.
101. Newburg, D.S. Oligosaccharides in human milk and bacterial colonization. J. Pediatr. Gastroenterol. Nutr. 2000, 30, S8-S17.
102. Cravioto, A.; Tello, A.; Villafan, H.; Ruiz, J.; del, V.S.; Neeser, J.R. Inhibition of localized adhesion of enteropathogenic Esherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J. Infect. Dis. 1991, 163, 1247-1255.
103. Mata, L.J.; Wyatt, R.G. The uniqueness of human milk. Host resistance to infection. Am. J. Clin. Nutr. 1971, 24, 976-986.
104. Caceres, A.; Mata, L.J. Indirect hemagglutination for the study of antibodies to enterobacteriaceae. Rev. Latinoam. Microbiol. 1970, 12, 137-144.
105. Hanson, L.A.; Winberg, J. Breast milk and defence against infection in the newborn. Arch. Dis. Child 1972, 47, 845-848.
106. Jelliffe, D.B. Active anti-infective properties of human milk. Lancet 1971, 2, 167-168.
107. Bessler, H.C.; de Oliveira, I.R.; Giugliano, L.G. Human milk glycoproteins inhibit the adherence of Salmonella typhimurium to HeLa cells. Microbiol. Immunol. 2006, 50, 877-882.
108. Willer, E.M.; Lima, R.L.; Giugliano, L.G. In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins. BMC Microbiol. 2004, 4, 18.